Minich Mac Gregor Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Minich Mac Gregor Wealth Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 09, 2023	BUY	$62.32 - $89.47 $36,644 - $52,608	588 New	588 $0
Q4 2018 Jan 17, 2019	SELL	$60.54 - $79.0 $7,567 - $9,875	-125 Closed	0 $0
Q2 2018 Jul 13, 2018	SELL	$64.88 - $75.68 $15,117 - $17,633	-233 Reduced 65.08%	125 $8,000
Q1 2018 Jul 03, 2018	BUY	$72.84 - $88.8 $2,258 - $2,752	31 Added 9.48%	358 $26,000
Q1 2017 Jun 28, 2018	SELL	N/A	-181 Reduced 35.63%	327 $22,000
Q4 2016 Jun 28, 2018	SELL	N/A	-199 Reduced 28.15%	508 $36,000
Q3 2016 Jun 28, 2018	BUY	N/A	1 Added 0.14%	707 $55,000
Q2 2016 Jun 28, 2018	SELL	N/A	-101 Reduced 12.52%	706 $58,000
Q1 2016 Jun 28, 2018	SELL	N/A	-182 Reduced 18.4%	807 $74,000
Q4 2015 Jun 27, 2018	BUY	N/A	989	989 $111,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Minich Mac Gregor Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Minich Mac Gregor Wealth Management, LLC with notifications on news.